Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 12:33 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 457–480 of 2,351 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Covid 19 Clear all

Conditions: COVID-19
Interventions: SARS-CoV-2; Diagnostic Test
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 18 Years and older
Enrollment: 236 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Chronic Lymphocytic Leukemia, COVID-19 Infection
Interventions: Biospecimen Collection, mRNA COVID-19 Vaccine, Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1; Procedure · Biological
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Duarte, California

Conditions: SARS-CoV 2
Interventions: Clungene rapid test cassette; Diagnostic Test
Lead sponsor: Fadi Haddad, M.D.; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 3
States / cities: La Mesa, California • San Diego, California

Conditions: COVID-19, Viral Respiratory Illnesses
Interventions: Nitazoxanide, Placebo, Vitamin Super B-Complex; Drug · Dietary Supplement
Lead sponsor: Romark Laboratories L.C.; Industry
Eligibility: 55 Years to 120 Years
Enrollment: 190 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 4
States / cities: Kissimmee, Florida • Acworth, Georgia • Lake Charles, Louisiana + 1 more

Conditions: Acute Respiratory Distress Syndrome, SARS-CoV-2
Interventions: PLN-74809, Placebo; Drug
Lead sponsor: Pliant Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 6
States / cities: Phoenix, Arizona • Los Angeles, California • Denver, Colorado + 3 more

Conditions: Chronic Pain
Interventions: painTRAINER®, Skills-Based VR; Behavioral · Device
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 13 Years and older
Enrollment: 330 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Chronic Respiratory Failure, Tracheostomy Complication, Mechanical Ventilation Complication
Interventions: COVID 19 vaccine counseling; Behavioral
Lead sponsor: Northwell Health; Other
Eligibility: Up to 21 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Lake Success, New York

Conditions: Covid19
Interventions: Fenofibrate/fenofibric acid, Placebo, Usual care; Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 701 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Covid19
Interventions: Wearable devices, saliva samples, survey measures; Other
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 2,381 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Adenovirus Infection, BK Virus Infection, Cytomegaloviral Infection, Hematopoietic and Lymphoid Cell Neoplasm, JC Virus Infection, Malignant Solid Neoplasm, Symptomatic COVID-19 Infection Laboratory-Confirmed
Interventions: Virus-specific Cytotoxic T-lymphocytes; Biological
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Covid19
Interventions: GSE and Xylitol, Control Placebo; Other · Drug
Lead sponsor: Larkin Community Hospital; Other
Eligibility: 18 Years to 90 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 2
States / cities: Miami, Florida

Conditions: SARS-Cov-2, Covid19
Interventions: POC SARS-Cov-2 IgG Antibody test; Diagnostic Test
Lead sponsor: Lumos Diagnostics; Industry
Eligibility: 1 Year and older
Enrollment: 201 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 3
States / cities: Colton, California • West Palm Beach, Florida • Chicago, Illinois

Conditions: COVID19, COVID-19, COVID
Interventions: Pacritinib, Placebo; Drug
Lead sponsor: CTI BioPharma; Industry
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 21
States / cities: Orange, California • Jacksonville, Florida • Atlanta, Georgia + 16 more

Conditions: COVID-19 Pneumonia
Interventions: Remdesivir, Tocilizumab, Placebo; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 12 Years and older
Enrollment: 649 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 38
States / cities: Phoenix, Arizona • Chula Vista, California • Irvine, California + 33 more

Conditions: Covid19
Interventions: Exercise Therapy; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 55 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: COVID-19
Interventions: AT-527, Placebo; Drug · Other
Lead sponsor: Atea Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 83 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 15
States / cities: Scottsdale, Arizona • Davis, California • Los Angeles, California + 11 more

Conditions: COVID-19
Interventions: Camostat Mesilate, Placebo; Drug
Lead sponsor: Sagent Pharmaceuticals Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 295 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 21
States / cities: Palm Springs, California • Bradenton, Florida • Brandon, Florida + 16 more

Conditions: Occupational Exposure to SARS-CoV-2, COVID-19
Interventions: Not listed
Lead sponsor: Villanova University; Other
Eligibility: 18 Years and older
Enrollment: 2,600 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Villanova, Pennsylvania

Conditions: COVID-19, Lymphocytopenia
Interventions: CYT107, Placebo; Drug
Lead sponsor: Revimmune; Industry
Eligibility: 25 Years to 80 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 2
States / cities: New York, New York • Houston, Texas

Conditions: Covid19, Fear, Loneliness
Interventions: Digital social activity video intervention, Informational sheet, Stigma awareness video intervention; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 1,200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: SARS-CoV-2, COVID-19 Vaccines
Interventions: Vaccination; Biological
Lead sponsor: Pfizer; Industry
Eligibility: Not listed
Enrollment: 19,853,610 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: COVID-19
Interventions: Facilitated Self-Sampling Intervention (FSSI), Testing Navigation Intervention (TNI)., Control; Behavioral
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 1,232 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 3
States / cities: Brownsville, Texas • Houston, Texas • Tyler, Texas

Conditions: Cerebrovascular Accident, Chronic Obstructive Pulmonary Disease, Chronic Renal Failure, Coronary Artery Disease, Diabetes Mellitus, Malignant Neoplasm, SARS Coronavirus 2 Infection
Interventions: Best Practice, Tocilizumab; Other · Biological
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: COVID-19, COVID19, Sars-CoV2, SARS-Cov-2
Interventions: Hydroxychloroquine, Placebo; Drug · Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Repeated Employee Testing for Understanding Our Recovery to Normal

A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia

IgG/IgM Antibody Test in Patients Who Have Tested Negative or Positive for COVID-19 With the Standard Method of COVID19 Testing.

Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF)

Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19

Pragmatic Comparative Effectiveness Trial of Evidence-based, On-demand, Digital Behavioral Treatments for Chronic Pain

Parental Perception of COVID-19 Vaccine in Technology Dependent Patients

FEnofibRate as a Metabolic INtervention for COVID-19

Studying Students at Risk for COVID-19

Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

Impact of GSE and Xylitol (Xlear) on COVID-19 Symptoms and Time to PCR Negativisation in COVID-19 Patients

Clinical Evaluation of a Point-of-Care (POC), SARS-CoV-2 (COVID-19) IgG Antibody Test in Fingerstick Whole Blood

PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer

A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia

Reconditioning Exercise for COVID-19 Patients Experiencing Residual sYmptoms

Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19) in a Hospital Setting

Camostat Efficacy vs. Placebo for Outpatient Treatment of COVID-19 (CAMELOT)

COVID-19 CHAMPS Study of Healthcare, First Responder and Service Workers

InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic Patients With COVID-19 Infection ( ILIAD-7-US-O )

Social Activity, Loneliness and Stigma During COVID-19 Outbreak

Effectiveness of BNT162b2 Formulations Using State Vaccine Registry and Insurance Claims Data

Examining How a Facilitated Self-Sampling Intervention and Testing Navigation Intervention Influences COVID-19 Testing

Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)

A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19